Request Demo
Last update 07 Feb 2025
Famotidine/magnesium dihydroxide/Calcium carbonate
Last update 07 Feb 2025
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms- |
Mechanism H2 receptor antagonists(Histamine H2 receptor antagonists), Proton pump inhibitors, Bone development modulators |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date US (16 Oct 2000), |
Regulation- |
Login to view timeline
Structure/Sequence
Molecular FormulaCH2CaO3 |
InChIKeyFYHXNYLLNIKZMR-UHFFFAOYSA-N |
CAS Registry471-34-1 |
View All Structures (3)
Related
3
Clinical Trials associated with Famotidine/magnesium dihydroxide/Calcium carbonateCTR20240252
法莫替丁钙镁咀嚼片在中国健康受试者中的单中心、随机、开放、空腹/餐后单次给药、两制剂、两周期、双交叉的生物等效性试验研究
[Translation] A single-center, randomized, open-label, single-dose, fasting/fed, two-formulation, two-period, double-crossover bioequivalence study of famotidine calcium magnesium chewable tablets in Chinese healthy subjects
NCT00944671
A Single-Dose, Open-Label, Three-Period Crossover Study to Assess the Bioequivalence of Famotidine/Antacid Combination Tablets (FACT) Compared to Famotidine/Antacid EZ Chew Tablet Without Water and Famotidine/Antacid EZ Chew Tablet With Water
CTR20244029
法莫替丁钙镁咀嚼片在中国健康受试者中的单中心、随机、开放、空腹/餐后单次给药、两制剂、两周期、双交叉的生物等效性试验研究
[Translation] A single-center, randomized, open-label, single-dose, fasting/fed, two-formulation, two-period, double-crossover bioequivalence study of famotidine calcium magnesium chewable tablets in Chinese healthy subjects
100 Clinical Results associated with Famotidine/magnesium dihydroxide/Calcium carbonate
Login to view more data
100 Translational Medicine associated with Famotidine/magnesium dihydroxide/Calcium carbonate
Login to view more data
100 Patents (Medical) associated with Famotidine/magnesium dihydroxide/Calcium carbonate
Login to view more data
100 Deals associated with Famotidine/magnesium dihydroxide/Calcium carbonate
Login to view more data
R&D Status
10 top approved records. to view more data
Login
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Heartburn | US | 16 Oct 2000 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Phase 1 | 24 | Famotidine (Famotidine/Antacid Combination EZ Chew Tablet Without Water) | svgbaduebn(rkyyzwtwrv) = khwcwuqgbj qoolqaptpf (hwtrltcrqa, xlbjsrhmdt - nydvpvaxmk) View more | - | 24 Jun 2015 | ||
Famotidine (Famotidine/Antacid Combination Tablet With Water) | svgbaduebn(rkyyzwtwrv) = cvkvgbkiso qoolqaptpf (hwtrltcrqa, nzqhtlhsdh - lblggdgncy) View more |
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free